Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Dropped 15.6% in First Three Quarters of 2023

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 109.7 million yuan in the first three quarters of 2023, down 15.6% year-on-year.

Meanwhile, the company posted 684.1 million yuan in revenue, up 0.4% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 405.5 million yuan in total liabilities, with a liability-to-asset ratio of 17.9%.